Journal article
Mini symposium: analysis of therapies for anovulation and miscarriage. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage
Abstract
Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage An alloimmune abnormality is believed to be the cause of recurrent miscarriage in couples in whom no other cause can be identified. Because of its immunosuppressive properties, intravenous immunoglobulin (IVIG) is used as a treatment for this disorder. The purpose of this study was to determine whether IVIG improves the chance of successful pregnancy in women with …
Authors
Daya S; Gunby J; Porter F; Scott J; Clark D
Journal
Human Reproduction Update, Vol. 5, No. 5, pp. 475–482
Publisher
Oxford University Press (OUP)
Publication Date
September 1, 1999
DOI
10.1093/humupd/5.5.475
ISSN
1355-4786